Method for manufacture of sertindole

Details for Australian Patent Application No. 2003215528 (hide)

Owner H. Lundbeck A/S

Inventors Zanon, Jacopo; Ciardella, Francesco; Villa, Marco

Agent Watermark

Pub. Number AU-B-2003215528

PCT Number PCT/DK03/00208

PCT Pub. Number WO2003/080597

Priority 60/368,434 27.03.02 US; PA 2002 00480 27.03.02 DK

Filing date 26 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 28 May 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

B01J 31/22 (2006.01) Catalysts comprising hydrides, coordination complexes or organic compounds

C07B 61/00 (2006.01) Other general methods

C07D 209/04 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07F 1/08 (2006.01) Compounds containing elements of the 1st Group of the Periodic System

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/368,434 27.03.02 US; PA 2002 00480 27.03.02 DK

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003215528

28 May 2009 Application Accepted

  Published as AU-B-2003215528

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215529-THE USE OF 3-(1-(2-(1-ACETYL-2,3-DIHYDRO-1H-I NDOL3-YL)ETHYL)-3,6-DIHYDRO-2H-PYRID IN-4-YL)-6-CHLORO-1H-INDOLE OR ITS ENANTIOMERS FOR THE TREATMENT OF DISEASES AND DISORDERS RESPONSIVE TO 5-HT (SEROTONIN) RE-UPTAKE INHIBITION

2003215527-IMPROVED BACILLUS HOST CELL